Published in Neurology on August 01, 1978
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (1992) 3.32
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol (2001) 1.35
Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol (2010) 1.08
Natalizumab and progressive multifocal leucoencephalopathy. Ann Rheum Dis (2006) 1.01
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med (2000) 5.43
Platelets and shear stress. Blood (1996) 4.18
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med (1982) 4.05
Herpesvirus hominis: isolation from human trigeminal ganglion. Science (1972) 3.97
Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest (1986) 2.28
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost (2008) 1.68
Disulfide bond reduction of von Willebrand factor by ADAMTS-13. J Thromb Haemost (2010) 1.59
Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood (1987) 1.57
Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med (2000) 1.48
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr (1992) 1.44
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest (1991) 1.41
Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. Blood (2001) 1.35
Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology (1985) 1.34
Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet (1988) 1.33
Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost (2005) 1.31
Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest (1987) 1.27
Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood (1993) 1.25
Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood (1992) 1.20
Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses. Am J Hematol (1979) 1.18
Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol (1990) 1.17
Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets. Thromb Res (1981) 1.16
Intrathoracic extramedullary hematopoiesis: report of a case in a patient with sickle-cell disease-beta-thalassemia. Am J Clin Pathol (1980) 1.10
Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost (2005) 1.10
Spiroplasma-like inclusions in Creutzfeldt-Jakob disease. Arch Pathol Lab Med (1979) 1.10
Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol (1986) 1.09
Platelet lysis and aggregation in shear fields. Blood Cells (1978) 1.09
Spontaneous hyphema associated with ingestion of aspirin and ethanol. Am J Ophthalmol (1976) 1.07
Acute polymyositis caused by sarcoidosis: report of a case and review of the literature. Mt Sinai J Med (1980) 1.07
Delayed and recurrent intracranial hematomas related to disseminated intravascular clotting and fibrinolysis in head injury. Neurosurgery (1980) 1.06
Additional evidence of spiroplasma in Creutzfeldt-Jakob disease. Lancet (1981) 1.03
Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions. Blood (1995) 1.02
The response of human platelets to shear stress at short exposure times. Trans Am Soc Artif Intern Organs (1977) 0.99
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol (1998) 0.98
Shear stress-induced binding of von Willebrand factor to platelets. Biorheology (1997) 0.95
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. J Thromb Haemost (2006) 0.93
Aspirin prevents heparin-induced platelet aggregation in vivo. Br J Haematol (1983) 0.92
Neuropathology of spiroplasma infection in the rat brain. Am J Pathol (1984) 0.92
von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia. Obstet Gynecol (1990) 0.91
Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol (1993) 0.90
Eastern equine encephalomyelitis. Histopathologic and ultrastructural changes with isolation of the virus in a human case. Am J Clin Pathol (1975) 0.89
Thrombosis following desmopressin for uremic bleeding. Am J Hematol (1988) 0.89
Herpesvirus varicellae isolated from human dorsal root ganglia. Arch Pathol (1974) 0.88
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood (1984) 0.88
Telangiectasia and von Willebrand's disease in two families. Ann Intern Med (1978) 0.87
Actinomycins and intrauterine contraceptive devices: the clinicopathologic study. Diagn Gynecol Obstet (1980) 0.87
The effect of PGI2 and theophylline on the response of platelets subjected to shear stress. Blood (1981) 0.87
TTP--desperation, empiricism, progress. N Engl J Med (1991) 0.86
Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions. Thromb Haemost (1998) 0.86
Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol (1989) 0.86
Platelets, von Willebrand factor, and prostaglandin I2. Am J Physiol (1981) 0.86
Neurovirulence in an experimental focal herpes encephalitis: relationship to observed seizures. Brain Res (1988) 0.85
Bernard-Soulier disease: a study of four patients and their parents. Br J Haematol (1981) 0.84
Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase. Biochim Biophys Acta (1970) 0.84
Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents. Thromb Haemost (1980) 0.83
Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost (2009) 0.83
Localization and persistence of spiroplasmas in an experimental brain infection in suckling rats. Ann Microbiol (Paris) (1984) 0.83
Inhibition of ristocetin-induced platelet agglutination by vancomycin. Blood (1977) 0.83
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation (1995) 0.83
Papova-like virus particles in a human brain tumor. Lab Invest (1971) 0.82
Inherited combined deficiency of factor V and factor VIII: report of a case with normal factor VIII antigen and ristocetin-induced platelet aggregation. Am J Hematol (1977) 0.82
Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Blood (1988) 0.82
Primitive neuroectodermal tumor in a 57-year-old man. Surg Neurol (1983) 0.81
Primary angiosarcoma of the brain. South Med J (1991) 0.81
Circulating IgG antibodies against factors IX and VIII in multiple sclerosis. Acta Haematol (1976) 0.81
Direct detection of red blood cell fragments: a new flow cytometric method to evaluate hemolysis in blood pumps. ASAIO J (2001) 0.81
Horseradish peroxidase labeled antisera--a diagnostic method for evaluating the percentages of B lymphocytes in peripheral blood. J Histochem Cytochem (1979) 0.81
Hemolytic anemia associated with multiple autoantibodies and low serum complement. Am J Med (1975) 0.80
Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood (1989) 0.80
In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass. Int J Artif Organs (2002) 0.80
Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol (1989) 0.79
Fibrinolysis inhibits shear stress-induced platelet aggregation. Circulation (1995) 0.79
Insolubilized von Willebrand factor and the initial events in hemostasis. J Lab Clin Med (1989) 0.79
The small midline occipital encephalomeningocele: definition of a syndrome. Neurosurgery (1989) 0.79
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy. Br J Cancer (1976) 0.78
Effects of antiplatelet agents on platelets exposed to shear stress. Trans Am Soc Artif Intern Organs (1980) 0.78
Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo. Am J Hematol (1991) 0.78
von Willebrand factor in thrombotic thrombocytopenic purpura. Blood (1986) 0.78
Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells. Cancer (1979) 0.78
Moschcowitz, multimers, and metalloprotease. N Engl J Med (1998) 0.78
Creutzfeldt-Jakob disease: procedures for handling diagnostic and research materials. Infect Control (1984) 0.78
Gliosarcoma developing from an irradiated ependymoma. Acta Neuropathol (1996) 0.78
Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets. J Lab Clin Med (1976) 0.78
Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine. Am J Hematol (1985) 0.78
Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng (1996) 0.77
Rheological studies of the contractile force within platelet-fibrin clots: effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP. Thromb Res (1978) 0.77
Malignant transformation in craniopharyngioma. Neurosurgery (1988) 0.77
Effects of Integrelin on platelet function in flow models of arterial thrombosis. J Cardiovasc Pharmacol (1997) 0.77
Intravascular hemolysis, thrombocytopenia, leukopenia, and circulating immune complexes after jejunal-ileal bypass surgery. Ann Intern Med (1977) 0.77
Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination. J Lab Clin Med (1980) 0.76
von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura. Am J Med Sci (1986) 0.76
Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion (1978) 0.75
A rare combination of multicentric gliomas: a problem of interpretation. Am J Clin Pathol (1970) 0.75
Postpartum thrombotic thrombocytopenic purpura complicated by Budd-Chiari syndrome. Obstet Gynecol (1995) 0.75
Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets. Thromb Res (1983) 0.75
Streptokinase-induced degradation of crosslinked and uncrosslinked clots. Thromb Res (1978) 0.75
Familial infantile thrombotic thrombocytopenic purpura. J Pediatr Hematol Oncol (1996) 0.75
Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation. Blood (1980) 0.75